Solta Medical Inc. 

(Public, NASDAQ:SLTM)   Watch this stock   
Find more results for NASDAQ:THRM
Nov 3, 2009
Q3 2009 Earnings Conference Call - Webcast
Nov 3, 2009
Q3 2009 Earnings Release
Sep 29, 2009
Maxim Group Conference
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin -35.18% -28.92%
Operating margin -36.88% -31.07%
EBITD margin - -28.43%
Return on average assets -18.33% -15.05%
Return on average equity -24.50% -19.76%
Employees 265 -

Address

25881 Industrial Boulevard
Hayward, CA 94545
United States - Map
+1-510-7822286 (Phone)
+1-510-7822287 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

Solta Medical Inc. discussed on blogs

Ranking 1100+ Micro Cap Stocks by Upside Potential - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 20, 2009

Solta Medical Inc. discussions

  View all discussions »

Description

Solta Medical Inc., formerly Thermage, Inc. is engaged in designing, developing, manufacturing and marketing energy-based medical device systems for aesthetic applications. These systems are marketed under the brand names Fraxel and Thermage and are Food & Drug Administration (FDA) cleared for dermatological procedures in the applications, which include: Skin Tightening, the Thermage NXT system offers non-invasive treatment options for skin tightening and contouring, body shaping, and improvement in the appearance of cellulite; Skin Rejuvenation, the Fraxel re:fine and Fraxel re:store systems offer treatments for skin conditions such as fine lines and pigmentation.

Officers and directors

Stephen J. Fanning
Chairman of the Board, President, Chief Executive Officer
Age: 57
Bio & Compensation - Reuters
John F. Glenn
Chief Financial Officer
Age: 47
Bio & Compensation - Reuters
Clint Carnell
Chief Operating Officer
Age: 39
Bio & Compensation - Reuters
Douglas W. Heigel
Vice President - Operations
Age: 48
Bio & Compensation - Reuters
William E. Brodie
Vice President - Global Sales
Age: 45
Bio & Compensation - Reuters
Jeffrey C. Nardoci
Vice President - Global Marketing
Bio & Compensation - Reuters
H. Daniel Ferrari
Vice President - Business and Financial Planning
Age: 50
Bio & Compensation - Reuters
Dragan D. Nebrigic
Vice President - Research & Development
Age: 46
Bio & Compensation - Reuters
Leonard C. DeBenedictis
Chief Technology Officer, Director
Age: 68
Bio & Compensation - Reuters
Edward W. Knowlton M.D.
Director
Age: 60
Bio & Compensation - Reuters